Research ArticleArticle
Development of a Radioligand, [3H]-LY2119620, to Probe the Human M2 and M4 Muscarinic Receptor Allosteric Binding Sites
Douglas A. Schober, Carrie H. Croy, Hongling Xiao, Arthur Christopoulos and Christian C. Felder
Molecular Pharmacology May 7, 2014, mol.114.091785; DOI: https://doi.org/10.1124/mol.114.091785
Douglas A. Schober
1 Eli Lilly and Company;
Carrie H. Croy
1 Eli Lilly and Company;
Hongling Xiao
1 Eli Lilly and Company;
Arthur Christopoulos
2 Monash University
Christian C. Felder
1 Eli Lilly and Company;
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
Research ArticleArticle
Development of a Radioligand, [3H]-LY2119620, to Probe the Human M2 and M4 Muscarinic Receptor Allosteric Binding Sites
Douglas A. Schober, Carrie H. Croy, Hongling Xiao, Arthur Christopoulos and Christian C. Felder
Molecular Pharmacology May 7, 2014, mol.114.091785; DOI: https://doi.org/10.1124/mol.114.091785
Research ArticleArticle
Development of a Radioligand, [3H]-LY2119620, to Probe the Human M2 and M4 Muscarinic Receptor Allosteric Binding Sites
Douglas A. Schober, Carrie H. Croy, Hongling Xiao, Arthur Christopoulos and Christian C. Felder
Molecular Pharmacology May 7, 2014, mol.114.091785; DOI: https://doi.org/10.1124/mol.114.091785
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement